Edition:
India

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

4.20USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
290,351
52-wk High
$7.88
52-wk Low
$3.90

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $890.11
Shares Outstanding(Mil.): 141.96
Dividend: --
Yield (%): --

Financials

BRIEF-Ziopharm Oncology reports third quarter financial results

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

07 Nov 2017

BRIEF-Ziopharm Oncology reports Q2 loss per share $0.13

* Ziopharm Oncology reports second quarter 2017 financial results and provides update on recent activities

01 Aug 2017

BRIEF-Ziopharm Oncology announces initiation of stereotactic treatment cohort in phase 1 study of Ad-RTS-hIL-12 + veledimex in recurrent glioblastoma

* Ziopharm Oncology announces initiation of stereotactic treatment cohort in phase 1 study of Ad-RTS-hIL-12 + veledimex in recurrent glioblastoma

28 Jun 2017

Earnings vs. Estimates